NIH Ebola patient's condition improves
The patient was originally admitted to the hospital on March 13 after volunteering as a healthcare worker in Sierra Leone. This individual is the second patient to be treated for EVD at the NIH Clinical Center Special Clinical Studies Unit. The first patient was treated successfully and discharged free of disease on Dec. 19.
Two additional individuals have been admitted with increased risk of exposure to the virus, but they were later found to be free of infection. The NIH follows Centers for Disease Control and Prevention (CDC) protocol in closely monitoring potential cases for a 21-day period.
The outbreak occurring in Sierra Leone, Liberia and Guinea has reported 25,178 possible cases and 14,764 confirmed cases, with 10,445 deaths as of Sunday, according to the CDC. This is considered to be one of the largest outbreaks of any strain of EVD in recent history.
Symptoms of EVD include vomiting, diarrhea, spontaneous bleeding or bruising and a high fever. The virus is spread through contact with infected bodily fluids that include blood or waste material.